PLIANT THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Percent
PLIANT THERAPEUTICS, INC. (PLRX) reported Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Percent of -0.20% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsOther · last filed 2025-03-03
- PLIANT THERAPEUTICS, INC. effective income tax rate reconciliation, tax settlement, other, percent for fiscal 2024 was -0.20%, a 300.00% decline from fiscal 2023.
- PLIANT THERAPEUTICS, INC. effective income tax rate reconciliation, tax settlement, other, percent for fiscal 2023 was 0.10%.
- PLIANT THERAPEUTICS, INC. effective income tax rate reconciliation, tax settlement, other, percent for fiscal 2022 was -0.40%.
- PLIANT THERAPEUTICS, INC. effective income tax rate reconciliation, tax settlement, other, percent for fiscal 2021 was -0.10%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Percent 12 month |
|---|---|
| 2024-12-31 | -0.20% 10-K · filed 2025-03-03 |
| 2023-12-31 | 0.10% 10-K · filed 2025-03-03 |
| 2022-12-31 | -0.40% 10-K · filed 2025-03-03 |
| 2021-12-31 | -0.10% 10-K · filed 2024-02-27 |
| 2020-12-31 | -0.10% 10-K · filed 2022-03-01 |
| 2019-12-31 | -2.40% 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |